Photodynamic therapy inhibits transforming growth factor β activity associated with vascular smooth muscle cell injury
- 30 June 1997
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 25 (6) , 1044-1053
- https://doi.org/10.1016/s0741-5214(97)70128-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Differential modulation of vascular endothelial and smooth muscle cell function by photodynamic therapy of extracellular matrix: Novel insights into radical-mediated prevention of intimal hyperplasiaJournal of Vascular Surgery, 1996
- Transforming growth factor beta: the good, the bad, and the ugly.The Journal of Experimental Medicine, 1994
- Pathobiology of intimal hyperplasiaBritish Journal of Surgery, 1994
- Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Journal of Clinical Investigation, 1994
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney diseaseNature, 1992
- Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.Journal of Clinical Investigation, 1992
- Transforming growth factor-beta in disease: the dark side of tissue repair.Journal of Clinical Investigation, 1992
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992
- Some recent advances in the chemistry and biology of transforming growth factor-beta.The Journal of cell biology, 1987
- Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from PlateletsScience, 1986